SCHEMBL4350119

SCHEMBL4350119

O=C1N=C(NCc2ccc3c(c2)OCO3)S/C1=C/c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.44
PIM1 P11309 2/20 0.43
PIM2 Q9P1W9 2/20 0.43
CHRM5 P08912 1/20 0.42
ALDH1A1 P00352 3/20 0.37
RAB9A P51151 1/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
PDE5A O76074 2/20 0.36
PTPN1 P18031 1/20 0.36
KCNH2 Q12809 1/20 0.36
MCHR1 Q99705 1/20 0.36
USP1 O94782 1/20 0.36
WDR48 Q8TAF3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350122 1.00 HPGD (0.48) HPGDSMN1; SMN2PIM1PIM2CHRM5
SCHEMBL4355546 0.88 HPGD (0.43) HPGDPIM1PIM2ALDH1A1HSD17B10
SCHEMBL4355549 0.88 HPGD (0.43) HPGDPIM1PIM2ALDH1A1HSD17B10
SCHEMBL4356536 0.80 ALOX5 (0.46) PIM1PIM2CHRM5MEN1KMT2A
SCHEMBL4356532 0.80 ALOX5 (0.46) PIM1PIM2CHRM5MEN1KMT2A
SCHEMBL4873444 0.77 CLK4 (0.45) HPGDPIM1ALDH1A1RAB9AMEN1
SCHEMBL4355388 0.75 KDM4E (0.47) HPGDSMN1; SMN2ALDH1A1RAB9AMAPT
SCHEMBL4355386 0.75 KDM4E (0.47) HPGDSMN1; SMN2ALDH1A1RAB9AMAPT
SCHEMBL4351555 0.74 MAPK1 (0.43) SMN1; SMN2ALDH1A1RAB9AMAPTHSD17B10
SCHEMBL4351083 0.72 ALDH1A1 (0.42) HPGDSMN1; SMN2ALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 HPGD 770/4885SMN1; SMN2 4570/4885PIM1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.